OTCMKTS:ORTIF

Ortho Regenerative Technologies (ORTIF) Stock Forecast, Price & News

$0.20

0.00 (0.00%)

(As of 09/9/2022)

Compare

Today's Range: $0.20
▼
$0.20
50-Day Range: $0.20
▼
$0.20
52-Week Range: $0.13
▼
$0.45

Volume: N/A
Average Volume: 3,282 shs
Market Capitalization: $6.86 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Headlines Short Interest

About Ortho Regenerative Technologies (OTCMKTS:ORTIF) Stock

Ortho Regenerative Technologies Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing, as well as ORTHO-T, a biopolymer formulation for tendon healing and regeneration. The company was incorporated in 2015 and is headquartered in Kirkland, Canada.

ORTIF Price History

30 days | 90 days | 365 days | Advanced Chart

ORTIF Stock News Headlines

September 27, 2023 | wsj.com

Medprin Regenerative Medical Technologies Co. Ltd. A

August 11, 2023 | uk.investing.com

Medprin Regenerative Medical Technologies Co Ltd (301033)

September 29, 2023 | Micro-Cap Stock Trader (Ad)

U.S. drive to onshore battery supply chains could create big winners in lithium

Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons

April 8, 2023 | markets.businessinsider.com

ChitogenX (CHNXF) Gets a Buy from Noble Financial

April 7, 2023 | marketwatch.com

Orthopedic Regenerative Surgical Products Market Revenue, Demand Status, Top Regions and Leading Players Analysis till 2030

February 22, 2023 | marketwatch.com

Ortho Phthalic Aldehyde Market Research Report 2023 By Leading Players, Emerging Technologies, Opportunity 2029

February 11, 2023 | finance.yahoo.com

St. Vincent's Orthopedics joins Hughston Clinic's Organization

January 7, 2023 | health.usnews.com

Best Hospitals for Orthopedics

September 29, 2023 | Micro-Cap Stock Trader (Ad)

U.S. drive to onshore battery supply chains could create big winners in lithium

Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons

October 15, 2022 | proactiveinvestors.com

ChitogenX shares jump on launch of its second orthopedic development program in meniscus repair

September 22, 2022 | newsweek.com

Top Specialized Hospitals - Orthopedics

September 10, 2022 | finance.yahoo.com

Hope Orthopedics of Oregon Expands Hand/Wrist Service with Dr. Allison Mitchell

September 8, 2022 | seekingalpha.com

Ortho Regenerative Technologies announces name change to ChitogenX Inc.

September 7, 2022 | finance.yahoo.com

ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES CORPORATE NAME CHANGE TO CHITOGENX

July 27, 2022 | finance.yahoo.com

ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES ENROLLMENT OF FIRST PATIENT IN ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL

June 24, 2022 | finance.yahoo.com

ORTHO REGENERATIVE TECHNOLOGIES REPORTS ITS FIRST QUARTER 2023 RESULTS

June 13, 2022 | finance.yahoo.com

ORTHO REGENERATIVE TECHNOLOGIES INITIATES PATIENTS RECRUITMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL

May 26, 2022 | finance.yahoo.com

ORTHO REGENERATIVE TECHNOLOGIES RECEIVES $500,000 AXELYS GRANT TO ADVANCE ORTHO-M DEVELOPMENT FOR MENISCUS REPAIR

May 21, 2022 | seekingalpha.com

Ortho Regenerative Technologies; GAAP EPS of -C$0.14

May 20, 2022 | finance.yahoo.com

ORTHO REGENERATIVE TECHNOLOGIES REPORTS ITS FOURTH QUARTER AND 2022 YEAR-END RESULTS

May 4, 2022 | seekingalpha.com

Ortho Regenerative gets US patent related to its soft tissue repair platform

May 4, 2022 | finance.yahoo.com

ORTHO REGENERATIVE TECHNOLOGIES RECEIVES KEY U.S. COMPOSITION AND METHOD PATENT FOR ORTHO-R SOFT TISSUE REPAIR PLATFORM

April 6, 2022 | finance.yahoo.com

ORTHO REGENERATIVE TECHNOLOGIES CLOSES OVERSUBSCRIBED NON-BROKERED PRIVATE PLACEMENT FOR $3.2 MILLION

March 24, 2022 | finance.yahoo.com

ORTHO REGENERATIVE TECHNOLOGIES TO PARTICIPATE IN THE 2022 VIRTUAL GROWTH CONFERENCE PRESENTED BY MAXIM GROUP LLC AND HOSTED BY M-VEST

March 21, 2022 | finance.yahoo.com

ORTHO REGENERATIVE TECHNOLOGIES AMENDS THE TERMS OF ITS $3 MILLION NON-BROKERED PRIVATE PLACEMENT OF UNITS

February 7, 2022 | finance.yahoo.com

ORTHO REGENERATIVE TECHNOLOGIES ENTERS INTO A MATERIAL TRANSFER AGREEMENT WITH A GLOBAL STRATEGIC MEDICAL COMPANY FOR ITS ORTHO-R ROTATOR CUFF TEAR REPAIR PHASE I/II U.S. CLINICAL TRIAL

December 21, 2021 | finance.yahoo.com

ORTHO REGENERATIVE TECHNOLOGIES REPORTS ITS THIRD QUARTER 2022 RESULTS

See More Headlines

Receive ORTIF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ortho Regenerative Technologies and its competitors with MarketBeat's FREE daily newsletter.

ORTIF Company Calendar

Today: 9/28/2023
Fiscal Year End: 1/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Surgical Appliances & Supplies
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:ORTIF
CUSIP: N/A
CIK: N/A
Web: www.orthorti.com
Phone: (514) 782-0951
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.11)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-3,930,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -269.68%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.26
Quick Ratio: 1.26

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.16) per share
Price / Book: -1.23

Miscellaneous

Outstanding Shares: 34,956,000
Free Float: N/A
Market Cap: $6.86 million
Optionable: Not Optionable
Beta: -1.16

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. Luc Mainville M.B.A (Age 58)
M.B.A., Sr. VP & CFO
Comp: $53.85k

Mr. Guy-Paul Allard
VP of Legal Affairs & Corp. Sec.

Mr. Philippe Deschamps (Age 60)
CEO, Pres & Director

Mr. Frederic Dumais
Director of Communications & Investor Relations

Dr. Jonathan Sackier
Chief Medical Officer

Benedek Simo
Controller

Key Competitors

View All Competitors

ORTIF Stock - Frequently Asked Questions

How have ORTIF shares performed in 2023?: Ortho Regenerative Technologies' stock was trading at $0.1962 at the start of the year. Since then, ORTIF stock has increased by 0.0% and is now trading at $0.1962.
View the best growth stocks for 2023 here.
What is Ortho Regenerative Technologies' stock symbol?: Ortho Regenerative Technologies trades on the OTCMKTS under the ticker symbol "ORTIF."

How do I buy shares of Ortho Regenerative Technologies?: Shares of ORTIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Ortho Regenerative Technologies' stock price today?: One share of ORTIF stock can currently be purchased for approximately $0.20.
How much money does Ortho Regenerative Technologies make?: Ortho Regenerative Technologies (OTCMKTS:ORTIF) has a market capitalization of $6.86 million. The company earns $-3,930,000.00 in net income (profit) each year or ($0.11) on an earnings per share basis.
How can I contact Ortho Regenerative Technologies?: The official website for the company is www.orthorti.com. The company can be reached via phone at (514) 782-0951 or via email at info@orthorti.com.

This page (OTCMKTS:ORTIF) was last updated on 9/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial